Speakers
David Ohlssen, PhD
Senior Expert Methodologist, Novartis Pharmaceuticals Corporation, United States
David Ohlssen is currently a senior expert statistical methodologist and Bayesian team lead, within the Novartis statistical methodology group, based in East Hanover New Jersey. His professional activities include serving as a member of the Bayesian DIA Working Group.
Amy Xia, PhD
Vice President, Center for Design and Analysis, Amgen Inc., United States
Amy Xia is Vice President, Center for Design and Analysis at Amgen. Amy has worked on designing, implementing, and analyzing Phase I-IV clinical trials as well as observational studies over the past two decades. Currently, she heads up the Center for Design and Analysis organization which includes Biostatistics, Design & Innovation and Data Sciences at Amgen, providing leadership and holistic vision for strategic drug development and driving innovative approaches across Amgen’s portfolios for evidence generation and decision-making. Amy received her PhD in Biostatistics from the University of Minnesota, and her medical degree from Peking University, China.
Have an account?